Nanoviricides, Inc.
Pharmaceutical company · Shelton, Connecticut, United States · NYSE: NNVC
Nanoviricides, Inc. is a pharmaceutical company headquartered in Shelton, Connecticut, United States. Its shares trade on NYSE under the ticker NNVC. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2026.
Nanoviricides at a glance
What does Nanoviricides do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $6 million sold (2026).
Frequently asked questions about Nanoviricides
Where is Nanoviricides headquartered?
Nanoviricides, Inc. is headquartered in Shelton, Connecticut, United States.
What does Nanoviricides do?
Nanoviricides, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Nanoviricides a public company?
Yes. Nanoviricides, Inc. trades on NYSE under the ticker NNVC.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences